Pharmacological Role of a Novel Dual-Targeting Hdacs/Microtubule Inhibitor 21-277 Inhibits Human Cancer Cells Growth in Vitro and in Vivo

Pharmacology, Toxicology and Pharmaceutical Science

1. Anticarcinogen 100%
2. Cancer Growth 100%
3. Microtubule Inhibitors 100%
4. Malignant Neoplasm 66%
5. Histone Deacetylase 66%
6. Prostate Cancer 50%
7. Neoplasm 50%
8. Indole Derivative 33%
9. Therapeutic Effect 33%
10. Leukemia 33%
11. Cancer Drug Development 33%
12. Protein Kinases 33%
13. Survival Rate 16%
14. Solid Malignant Neoplasm 16%
15. Histone Deacetylase Inhibitor 16%
16. Combination Drug 16%
17. Drug Resistance 16%